Trial site
Southern Endocrinology Associates
- 16running trials
- 15closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Type 2 diabetes16 trials
- Obesity13 trials
- Type 1 diabetes4 trials
- Chronic kidney disease2 trials
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Peripheral artery disease1 trial
- Stroke1 trial
- Phase
- Phase 324 trials
- Phase 26 trials
- Phase 41 trial
- Status
- Completed15 trials
- Active, not recruiting10 trials
- Recruiting5 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company24 trials
- Ionis Pharmaceuticals, Inc.4 trials
- Boehringer Ingelheim2 trials
- Zucara Therapeutics Inc.1 trial
Running trials
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Recruiting
A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia
Recruiting
Active, not recruiting
A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes4 recruiting
- Obesity2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- High blood pressure1 recruiting
- Type 1 diabetes1 recruiting
Closed trials
Completed
Completed
Completed
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
Completed
Completed
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
Completed
Completed
Completed
Completed
Completed
Completed
A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
Site data: ClinicalTrials.govUpdated 18 Nov 2026